Literature DB >> 15534307

Vagus nerve stimulation in the treatment of epilepsy.

Alan Guberman1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15534307      PMCID： PMC524944          DOI： 10.1503/cmaj.1041039

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

Review 1.  Vagus nerve stimulation therapy summary: five years after FDA approval.

Authors:  Steven C Schachter
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

2.  Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures.

Authors:  C M DeGiorgio; S C Schachter; A Handforth; M Salinsky; J Thompson; B Uthman; R Reed; S Collins; E Tecoma; G L Morris; B Vaughn; D K Naritoku; T Henry; D Labar; R Gilmartin; D Labiner; I Osorio; R Ristanovic; J Jones; J Murphy; G Ney; J Wheless; P Lewis; C Heck
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

3.  A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group.

Authors: 
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

Review 4.  Therapeutic mechanisms of vagus nerve stimulation.

Authors:  Thomas R Henry
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

5.  Vagus nerve stimulation therapy in patients younger than 18 years.

Authors:  James W Wheless; Vijay Maggio
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

6.  Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial.

Authors:  A Handforth; C M DeGiorgio; S C Schachter; B M Uthman; D K Naritoku; E S Tecoma; T R Henry; S D Collins; B V Vaughn; R C Gilmartin; D R Labar; G L Morris; M C Salinsky; I Osorio; R K Ristanovic; D M Labiner; J C Jones; J V Murphy; G C Ney; J W Wheless
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910
  6 in total
  3 in total

1.  The beginning of intracellular recording in spinal neurons: facts, reflections, and speculations.

Authors:  Douglas G Stuart; Robert M Brownstone
Journal:  Brain Res       Date:  2011-06-12       Impact factor: 3.252

2.  Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis.

Authors:  Jared M Huston; Mahendar Ochani; Mauricio Rosas-Ballina; Hong Liao; Kanta Ochani; Valentin A Pavlov; Margot Gallowitsch-Puerta; Mala Ashok; Christopher J Czura; Brian Foxwell; Kevin J Tracey; Luis Ulloa
Journal:  J Exp Med       Date:  2006-06-19       Impact factor: 14.307

Review 3.  Montelukast: The New Therapeutic Option for the Treatment of Epilepsy.

Authors:  Bekalu Amare Tesfaye; Haftom Gebregergs Hailu; Kaleab Alemayehu Zewdie; Muluken Altaye Ayza; Derbew Fikadu Berhe
Journal:  J Exp Pharmacol       Date:  2021-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.